STK22B Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP7190a
Background:
STK22B is involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. This protein may play a part in the etiology of the velocardiofacial/DiGeorge syndrome (VCFS/DGS), a developmental disorder characterized by structural and functional palate anomalies, conotruncal cardiac malformations, immunodeficiency, hypocalcemia, and typical facial anomalies.
Other Names:
Testis-specific serine/threonine-protein kinase 2, TSK-2, TSK2, TSSK-2, Testis-specific kinase 2, DiGeorge syndrome protein G, DGS-G, Serine/threonine-protein kinase 22B, TSSK2, DGSG, SPOGA2, STK22B
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7190a was selected from the N-term region of human STK22B. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: TSSK2
Gene ID: 23617
Primary Accession: Q96PF2
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
STK22B is involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. This protein may play a part in the etiology of the velocardiofacial/DiGeorge syndrome (VCFS/DGS), a developmental disorder characterized by structural and functional palate anomalies, conotruncal cardiac malformations, immunodeficiency, hypocalcemia, and typical facial anomalies.
Other Names:
Testis-specific serine/threonine-protein kinase 2, TSK-2, TSK2, TSSK-2, Testis-specific kinase 2, DiGeorge syndrome protein G, DGS-G, Serine/threonine-protein kinase 22B, TSSK2, DGSG, SPOGA2, STK22B
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7190a was selected from the N-term region of human STK22B. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: TSSK2
Gene ID: 23617
Primary Accession: Q96PF2
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review